Evidence map›Paper›PMID 30111568›Full record

ArticleJournal of virology2018

The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines.

Keisuke Nakagawa, Krishna Narayanan, Masami Wada, Vsevolod L Popov, Maria Cajimat, Ralph S Baric, Shinji Makino

Abstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress response.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Keisuke NakagawaDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas, USA.
Krishna NarayananDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas, USA.
Masami WadaDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas, USA.
Vsevolod L PopovDepartment of Pathology, The University of Texas Medical Branch, Galveston, Texas, USA.
Maria CajimatDepartment of Pathology, The University of Texas Medical Branch, Galveston, Texas, USA.
Ralph S BaricDepartment of Epidemiology and Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Shinji MakinoDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas, USA shmakino@utmb.edu.
The University of Texas Medical Branch at Galveston · USUniversity of North Carolina at Chapel Hill · US

Funding

Mechanisms of MERS-CoV Entry, Cross-species Transmission and PathogenesisR01AI110700 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, LI, FANG · 2015 to 2024
$7.4M
Determinants of Coronavirus Fidelity in Replication and PathogenesisR01AI108197 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BARIC, RALPH S, DENISON, MARK R · 2013 to 2022
$6.5M
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1R01AI114657 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MAKINO, SHINJI · 2015 to 2019
$2.1M
Analysis of Coronavirus-Host Cell InteractionsR01AI099107 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MAKINO, SHINJI · 2012 to 2016
$2.0M
NIAID NIH HHS R01 AI099107NIAID NIH HHS R01 AI108197NIAID NIH HHS R01 AI110700NIAID NIH HHS R01 AI114657
6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) nsp1 suppresses host gene expression in expressed cells by inhibiting translation and inducing endonucleolytic cleavage of host mRNAs, the latter of which leads to mRNA decay. We examined the biological functions of nsp1 in infected cells and its role in virus replication by using wild-type MERS-CoV and two mutant viruses with specific mutations in the nsp1; one mutant lacked both biological functions, while the other lacked the RNA cleavage function but retained the translation inhibition function. In Vero cells, all three viruses replicated efficiently with similar replication kinetics, while wild-type virus induced stronger host translational suppression and host mRNA degradation than the mutants, demonstrating that nsp1 suppressed host gene expression in infected cells. The mutant viruses replicated less efficiently than wild-type virus in Huh-7 cells, HeLa-derived cells, and 293-derived cells, the latter two of which stably expressed a viral receptor protein. In 293-derived cells, the three viruses accumulated similar levels of nsp1 and major viral structural proteins and did not induce

Indexed as

AnimalsCell LineChlorocebus aethiopsCoronavirus InfectionsGene ExpressionHEK293 CellsHeLa CellsHumansInterferon-betaInterferon-gammaMiddle East Respiratory Syndrome CoronavirusRNA CleavageRNA, MessengerRNA StabilityVero CellsViral Nonstructural ProteinsIFNG protein, humanInterferon-betaInterferon-gammaRNA, MessengerViral Nonstructural ProteinsMERS coronavirusnsp1virus assembly/budding

Identifiers

PMID30111568
PMCPMC6189501
OpenAlexW2887342775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.